Literature DB >> 22350228

Outcome of endoscopic retrograde cholangiopancreatography during live endoscopy demonstrations.

Wiriyaporn Ridtitid1, Rungsun Rerknimitr, Sombat Treeprasertsuk, Pradermchai Kongkam, Christopher J L Khor, Pinit Kullavanijaya.   

Abstract

BACKGROUND: A number of factors may result in lower than expected success rates for endoscopic retrograde cholangiopancreatography (ERCP) performed by overseas experts during live demonstrations (LDs). Stratifying the degree of ERCP difficulty may help in the assessment of procedure outcomes, but no prior reports have done so. This study aimed to compare the success rate and complications of ERCP between procedures performed in live demonstrations and for matched control subjects.
METHODS: From 2004 to 2011, a total of 82 patients who underwent ERCP during live demonstrations at the Endoscopy Unit of King Chulalongkorn Memorial Hospital were reviewed. The control for each patient was a patient admitted to the same ERCP unit with matched indications at the time closest to the demonstration course who had matching gender and techniques in therapeutic interventions during ERCP. The success rates and complications between the two groups were compared based on the grading scale for the degree of difficulty according to Cotton and colleagues.
RESULTS: For standard ERCP cases (levels 1-2), the success rate, complication rate, and duration of the procedure (DOP) did not differ significantly. In contrast, the success rate for complex ERCPs (levels 3-4) performed during LD was significantly lower (73% vs. 90%; P = 0.006). The complication rates and DOP were not significantly different (P = 0.31 and 0.23, respectively). The overall success rate was significantly lower for LD procedures than for control procedures (81% vs. 91%; P = 0.02).
CONCLUSIONS: In this series, the standard ERCP performed during LD was associated with success and complication rates similar to those for the control subjects. Complex ERCP cases were, however, associated with lower success rates than those for the control subjects. A high proportion of complex ERCP cases during live demonstration can influence the overall success rate of ERCPs performed by overseas experts.

Entities:  

Mesh:

Year:  2012        PMID: 22350228     DOI: 10.1007/s00464-011-2130-2

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  13 in total

1.  A guideline for live endoscopy courses: an ASGE White Paper.

Authors:  D L Carr-Locke; C J Gostout; J Van Dam
Journal:  Gastrointest Endosc       Date:  2001-05       Impact factor: 9.427

2.  Live endoscopy demonstrations are great, but...

Authors:  P B Cotton
Journal:  Gastrointest Endosc       Date:  2000-05       Impact factor: 9.427

3.  Recommendations of the ESGE workshop on Ethical-Legal Issues Concerning Live Demonstrations in Digestive Endoscopy. First European Symposium on Ethics in Gastroenterology and Digestive Endoscopy, Kos, Greece, June 2003.

Authors:  J Devière; T Ponchon; U Beilenhoff; H Neuhaus; G Costamagna; A Schmit; A Kruse; J Spicak; A Nowak
Journal:  Endoscopy       Date:  2003-09       Impact factor: 10.093

Review 4.  Quality indicators for endoscopic retrograde cholangiopancreatography.

Authors:  Todd H Baron; Bret T Petersen; Klaus Mergener; Amitabh Chak; Jonathan Cohen; Stephen E Deal; Brenda Hoffman; Brian C Jacobson; John L Petrini; Michael A Safdi; Douglas O Faigel; Irving M Pike
Journal:  Gastrointest Endosc       Date:  2006-04       Impact factor: 9.427

5.  Cardiopulmonary complications of ERCP in older patients.

Authors:  Leon Fisher; Alexander Fisher; Andrew Thomson
Journal:  Gastrointest Endosc       Date:  2006-06       Impact factor: 9.427

6.  Complications of endoscopic retrograde cholangiopancreatography during live endoscopy workshop demonstrations.

Authors:  A Schmit; G Lazaraki; A Hittelet; M Cremer; O Le Moine; J Devière
Journal:  Endoscopy       Date:  2005-08       Impact factor: 10.093

7.  Risk factors for complications after ERCP: a multivariate analysis of 11,497 procedures over 12 years.

Authors:  Peter B Cotton; Donald A Garrow; Joseph Gallagher; Joseph Romagnuolo
Journal:  Gastrointest Endosc       Date:  2009-03-14       Impact factor: 9.427

8.  How safe and successful are live demonstrations of therapeutic ERCP? A large multicenter study.

Authors:  Zhuan Liao; Zhao-Shen Li; Joseph W Leung; Xiao Zhang; Shu-Tian Zhang; Ming Ji; Zhi-Ning Fan; Fa-Chao Zhi; You-Ming Li; Xiao-Xing Chen; Lin Lu; Xu Ren; Guo-Fa Jia; Liu-Ye Huang; Nong-Hua Lv; Wei-Feng Xie; Zhi-Zheng Ge; William S C Chao
Journal:  Am J Gastroenterol       Date:  2009-01       Impact factor: 10.864

Review 9.  Incidence rates of post-ERCP complications: a systematic survey of prospective studies.

Authors:  Angelo Andriulli; Silvano Loperfido; Grazia Napolitano; Grazia Niro; Maria Rosa Valvano; Fulvio Spirito; Alberto Pilotto; Rosario Forlano
Journal:  Am J Gastroenterol       Date:  2007-05-17       Impact factor: 10.864

Review 10.  Adverse outcomes of endoscopic retrograde cholangiopancreatography: avoidance and management.

Authors:  Martin L Freeman
Journal:  Gastrointest Endosc Clin N Am       Date:  2003-10
View more
  3 in total

Review 1.  Safety and effectiveness of live broadcast of surgical procedures: systematic review.

Authors:  Mina Awad; Manish Chowdhary; Shady Hermena; Sara El Falaha; Naim Slim; Nader K Francis
Journal:  Surg Endosc       Date:  2022-05-23       Impact factor: 3.453

2.  Outcomes of large colorectal polyp endoscopic resections during small audience live endoscopy events with endoscopist at their home endoscopy unit.

Authors:  Ahmed El Rahyel; Douglas K Rex
Journal:  Endosc Int Open       Date:  2022-10-17

3.  Impact of introduction of endoscopic ultrasound on volume, success, and complexity of endoscopic retrograde cholangiopancreatography in a tertiary referral center.

Authors:  Harathi Yandrapu; Sherif Elhanafi; Farhanaz Chowdhury; Jiayang Liu; Eduardo J Onate; Alok Dwivedi; Mohamed O Othman
Journal:  Endosc Ultrasound       Date:  2017 Jul-Aug       Impact factor: 5.275

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.